Blue Bell Private Wealth Management LLC acquired a new position in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) in the 3rd quarter, Holdings Channel reports. The firm acquired 89,467 shares of the company’s stock, valued at approximately $1,290,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Royal Bank of Canada lifted its stake in shares of BlackRock Health Sciences Term Trust by 326.9% in the 1st quarter. Royal Bank of Canada now owns 1,594,157 shares of the company’s stock valued at $23,753,000 after purchasing an additional 1,220,764 shares during the last quarter. Bank of America Corp DE raised its holdings in BlackRock Health Sciences Term Trust by 6.2% in the 2nd quarter. Bank of America Corp DE now owns 1,473,986 shares of the company’s stock valued at $21,019,000 after buying an additional 86,374 shares during the period. RFG Advisory LLC acquired a new position in BlackRock Health Sciences Term Trust in the second quarter valued at about $858,000. Jane Street Group LLC lifted its position in BlackRock Health Sciences Term Trust by 157.1% in the second quarter. Jane Street Group LLC now owns 97,472 shares of the company’s stock valued at $1,390,000 after buying an additional 59,559 shares during the last quarter. Finally, Penserra Capital Management LLC boosted its stake in BlackRock Health Sciences Term Trust by 3.0% during the second quarter. Penserra Capital Management LLC now owns 1,157,004 shares of the company’s stock worth $16,498,000 after buying an additional 34,191 shares during the period.
Insiders Place Their Bets
In other BlackRock Health Sciences Term Trust news, Director Robert W. Fairbairn sold 10,294 shares of the business’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $14.98, for a total value of $154,204.12. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.
BlackRock Health Sciences Term Trust Trading Down 0.5%
BlackRock Health Sciences Term Trust Dividend Announcement
The business also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, March 13th will be issued a $0.11 dividend. This represents a c) annualized dividend and a yield of 8.8%. The ex-dividend date is Friday, March 13th.
BlackRock Health Sciences Term Trust Profile
BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.
The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.
Featured Articles
- Five stocks we like better than BlackRock Health Sciences Term Trust
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- BNZI: BNZI Surges Ahead as AI Marketing Fuels Record Revenue
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
